David A. Lomas
- Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms 78
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 22
- Cell Biology top 0.5%
- Endoplasmic Reticulum Stress and Disease 23
- Cellular transport and secretion 16
- Calpain Protease Function and Regulation 11
- Molecular Biology top 1%
- Signaling Pathways in Disease 18
- Oncology top 2%
- Peptidase Inhibition and Analysis 28
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 10
- Co-authors
- Robin W. CarrellBibek GooptuRavi MahadevaElena MirandaStefan J. MarciniakPeter R. ElliottTimothy R. DaffornNoel G. McElvaney
- Journals
- Journal of Biological Chemistry (8 papers)FEBS Journal (7 papers)American Journal of Respiratory Cell and Molecular Biology (5 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
David A. Lomas
132 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 3.6k
- Hematology 1.5k
- Cell Biology 2.0k
- Molecular Biology 4.3k
- Oncology 1.6k
Countries citing papers authored by David A. Lomas
This map shows the geographic impact of David A. Lomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Lomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Lomas more than expected).
Fields of papers citing papers by David A. Lomas
This network shows the impact of papers produced by David A. Lomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Lomas. The network helps show where David A. Lomas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David A. Lomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 31 | |
| 9 | 2019 | 15 | |
| 10 | 2019 | 12 | |
| 11 | 2017 | 62 | |
| 12 | 2015 | 29 | |
| 13 | 2014 | 23 | |
| 14 | 2014 | 29 | |
| 15 | 2013 | 18 | |
| 16 | 2012 | 39 | |
| 17 | 2009 | 37 | |
| 18 | Abstract 718: Mammalian Serine Protease Inhibitor (Serpin), Neuroserpin, Targets Thromblytic Proteases to Reduce Inflammation, Atherogenesis and T Helper Lymphocyte Activation | 2007 | 0 |
| 19 | 2004 | 42 | |
| 20 | 2002 | 167 |
About David A. Lomas
David A. Lomas is a scholar working on Cancer Research, Cell Biology, Hematology, Aging and Oncology, having authored 135 papers that have together received 8.8k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (78 papers), Peptidase Inhibition and Analysis (28 papers), Endoplasmic Reticulum Stress and Disease (23 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers), Signaling Pathways in Disease (18 papers), Cellular transport and secretion (16 papers), Calpain Protease Function and Regulation (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). The work is most often cited by research in Cancer Research (3.6k citations), Hematology (1.5k citations), Cell Biology (2.0k citations), Molecular Biology (4.3k citations) and Oncology (1.6k citations). David A. Lomas has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robin W. Carrell, Bibek Gooptu, Ravi Mahadeva, Elena Miranda, Stefan J. Marciniak, Peter R. Elliott, Timothy R. Dafforn, Noel G. McElvaney, James A. Irving and Damian C. Crowther. Their work appears in journals such as Journal of Biological Chemistry, FEBS Journal, American Journal of Respiratory Cell and Molecular Biology, Journal of Molecular Biology and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.